Source: The United States Department of Justice Department of Justice Office of Public Affairs FOR IMMEDIATE RELEASE Thursday, October 29, 2015 Former President and Three District Managers Also Face Criminal Charges Warner Chilcott U.S. Sales LLC, a subsidiary of pharmaceutical manufacturer Warner Chilcott PLC, has agreed to plead guilty…...
![](https://www.qfrsolutions.com/wp-content/uploads/2016/12/Val-880x370.png)
Valeant Shares Nosedive on Short Seller’s ‘Phantom Sales’ Allegations
Source: Valeant has faced its fair share of questions from lawmakers, prosecutors and presidential candidates over the past several weeks--and now, it's facing a whole lot more from investors. The company's stock tanked by nearly 40% on Wednesday on a report from short seller Citron Research, which likened Valeant to…...
![](https://www.qfrsolutions.com/wp-content/uploads/2015/10/kybella.jpg)
Allergan Plots 117 Job Cuts in the Wake of Kythera Buyout
Source: The job-cutting ax has been hovering over Kythera Biopharmaceuticals ever since Allergan ($AGN) agreed to buy the company in April. Now, that ax is getting ready to fall. According to a notice filed with the state of California, Kythera will lay off 117 employees at its Westlake Village, CA,…...
![](https://www.qfrsolutions.com/wp-content/uploads/2015/10/drugpricebig-700x370.jpg)
Big Pharma Teams Up to Defeat Drug Pricing Proposal in California
Source: California wants to cap drug prices, but Big Pharma isn't having it. Amid a growing backlash over drug pricing, companies such as Johnson & Johnson ($JNJ) and Bristol-Myers Squibb ($BMY) are funneling millions of dollars into stamping out a new proposal that would curb drug spending in the state.…...
![](https://www.qfrsolutions.com/wp-content/uploads/2015/10/RES.jpg)
Avita Nabs $54M BARDA Contract For Ongoing Pivotal Trial, Stockpile of Burn Injury Device
Source: FierceBiotech Tiny OTC-traded micro-cap Avita Medical ($AVMXY) has won backing from the U.S. Biomedical Advanced Research and Development Authority (BARDA) of its PMA approval trial for its ReCell burn treatment device. It will get $16.9 million upfront for the study and for procurement of more than 5,000 of the…...